Actively Recruiting
Ongoing Observation of Medtronic Neurovascular Devices for Treating Intracranial Aneurysm and Acute Ischemic Stroke
Led by Medtronic Neurovascular Clinical Affairs · Updated on 2026-09-15
4000
Participants Needed
99
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to observe and evaluate the safety and effectiveness of Medtronic Neurovascular devices used in treating intracranial aneurysms and acute ischemic stroke. It is a prospective, multi-center, single-arm registry designed for ongoing product surveillance and periodic reporting. The study includes patients treated with market-approved Medtronic devices to gather real-world data on these conditions. Participants receive treatment involving embolization for intracranial aneurysms or revascularization for acute ischemic stroke using Medtronic devices. This observational registry collects data from patients undergoing these treatments without assigning specific interventions, reflecting routine clinical care practices. The study continues to enroll and monitor patients over an extended period. During participation, patients are observed and followed up to assess clinical success, defined as complete occlusion of the aneurysm without retreatment or significant artery narrowing at one year, and functional independence measured by the mRS score at 90 days. Researchers collect information from medical records and follow-up visits to monitor outcomes and safety. The study spans multiple years, with ongoing data collection up to August 2032.
CONDITIONS
Brief Title
Neurovascular Product Surveillance Registry
Research Team
W
Wouter Fabry
B
Beatrice Carlotta Sicurella
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here